Delivery of Molecular and Nanoscale Medicine to Tumors: Transport Barriers and Strategies
The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Abstract
Tumors are similar to organs, with unique physiology giving rise to an unusual set of transport barriers to drug delivery. Cancer therapy is limited by nonuniform drug delivery via blood vessels, inhomogeneous drug transport into tumor interstitium from the vascular compartment, and hindered transport through tumor interstitium to the target cells. Four major abnormal physical and physiological properties contribute to these transport barriers. Accumulated solid stress compresses blood vessels to diminish the drug supply to many tumor regions. Immature vasculature with high viscous and geometric resistances and reduced pressure gradients leads to sluggish and heterogeneous blood flow in tumors to further limit drug supply. Nonfunctional lymphatics coupled with highly permeable blood vessels result in elevated hydrostatic pressure in tumors to abrogate convective drug transport from blood vessels into and throughout most of the tumor tissue. Finally, a dense structure of interstitial matrix and cells serves as a tortuous, viscous, and steric barrier to diffusion of therapeutic agents. In this review, we discuss the origins and implications of these barriers. We then highlight strategies for overcoming these barriers by modulating either drug properties or the tumor microenvironment itself to enhance the delivery and effectiveness of drugs in tumors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is, however, still different from the actual situation in the human body where shear stresses also exist inside the tumor [161].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [161]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Self-citationNormalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Self-citationHypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Renal clearance of quantum dots
Soo Choi, H., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., & Frangioni, J. V. (2007) · Nature Biotechnology · doi:10.1038/nbt1340 · Cited by 4,476
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Delivering nanomedicine to solid tumors
Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,180
Self-citationOlive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Dvorak, H. F., Brown, L. F., Detmar, M. J., & Dvořàk, A. M. (1995) · Europe PMC (PubMed Central) · Cited by 3,115
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805
Research works printed but not linked: 24
- Griffon-Etienne G, 1999, Cancer Res., 59, 3776
- Leu AJ, 2000, Cancer Res., 60, 4324
- Leunig M, 1992, Cancer Res., 52, 6553
- Sevick EM, 1989, Cancer Res., 49, 3513
- Sevick EM, 1989, Cancer Res., 49, 3506
- Yuan F, 1994, Cancer Res., 54, 4564
- Boucher Y, 1992, Cancer Res., 52, 5110
- Netti PA, 1995, Cancer Res., 55, 5451
- Netti PA, 2000, Cancer Res., 60, 2497
- Jain RK, 2010, Nat. Rev., 7, 653
- Jain RK., 1988, Cancer Res., 48, 2641
- Endrich B, 1979, J. Natl. Cancer Inst., 62, 387
- Boucher Y, 1990, Cancer Res., 50, 4478
- Jain RK, 1988, Cancer Res., 48, 7022
- Dvorak HF, 1995, Am. J. Pathol., 146, 1029
- Roberts WG, 1997, Cancer Res., 57, 765
- Yuan F, 1994, Cancer Res., 54, 3352
- Znati CA, 2003, Clin. Cancer Res., 9, 5508
- Winkler F, 2004, Cancer Cell, 6, 553
- Lee CG, 2000, Cancer Res., 60, 5565
- Yuan F, 1995, Cancer Res., 55, 3752
- Nugent LJ, 1984, Cancer Res., 44, 238
- Campbell RB, 2002, Cancer Res., 62, 6831
- Schmitt-Sody M, 2003, Clin. Cancer Res., 9, 2335
Cited by
Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities
Cheng, Z., Al Zaki, A., Hui, J. Z., Muzykantov, V. R., & Tsourkas, A. (2012) · Science · doi:10.1126/science.1226338 · Cited by 1,322
Tumor targeting via EPR: Strategies to enhance patient responses
Golombek, S. K., May, J.-N., Theek, B., Appold, L., Drude, N., Kiessling, F., & Lammers, T. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.007 · Cited by 1,262
“normalize the disorganized tumor vasculature of highly vascularized tumors to improve nanomedicine delivery [62].”
BackgroundChallenges and strategies in anti-cancer nanomedicine development: An industry perspective
Hare, J. I., Lammers, T., Ashford, M. B., Puri, S., Storm, G., & Barry, S. T. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.025 · Cited by 1,214
Chauhan, V. P., Stylianopoulos, T., Martin, J. D., Popović, Z., Chen, O., Kamoun, W. S., Bawendi, M. G., Fukumura, D., & Jain, R. K. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.45 · Cited by 1,101
Self-citationRational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization
Sun, Q., Zhou, Z., Qiu, N., & Shen, Y. (2017) · Advanced Materials · doi:10.1002/adma.201606628 · Cited by 1,058
Metadata
- Authors
- Chauhan, V. P., Stylianopoulos, T., Boucher, Y., & Jain, R. K.
- Affiliations
- Harvard University (US)
- Venue
- Annual Review of Chemical and Biomolecular Engineering
- Publisher
- Annual Reviews
- Published
- 2011-07-15
- Volume
- 2
- Issue
- 1
- Pages
- 281-298
- ISSN
- 1947-5438 (ISSN-L)
- 1947-5446
- OpenAlex
- W2167798860
- Cited by
- 597
- References
- 124
- Citations by year
- 2026: 27 · 2025: 37 · 2024: 26 · 2023: 35 · 2022: 47 · 2021: 41 · 2020: 38 · 2019: 52 · 2018: 55 · 2017: 50 · 2016: 41 · 2015: 49 · 2014: 32 · 2013: 46 · 2012: 15
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Chemical and Biomolecular Engineering (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R01CA115767, R01 CA 85140, T32CA073479, T32-CA73479, R01CA98706, R01CA085140, P01CA080124, R01CA126642, R01CA098706, P01-CA-80124)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- tumor drug delivery, tumor microenvironment, solid stress, tumor vasculature, tumor perfusion, interstitial fluid pressure, interstitial matrix, steric hindrance, nanomedicine, molecular medicine, tumor heterogeneity, drug delivery barriers
- MeSH terms
- Animals, Biological Transport, Capillary Permeability, Extracellular Space, Humans, Neoplasms, Drug Delivery Systems, Nanostructures, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Delivery of Molecular and Nanoscale Medicine to Tumors: Transport Barriers and Strategies. https://app.cochat.ai/papers/10.1146/annurev-chembioeng-061010-114300
- The paper
- Chauhan, V. P., Stylianopoulos, T., Boucher, Y., & Jain, R. K. (2011). Delivery of Molecular and Nanoscale Medicine to Tumors: Transport Barriers and Strategies. Annual Review of Chemical and Biomolecular Engineering. https://doi.org/10.1146/annurev-chembioeng-061010-114300
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.